Tower Research Capital LLC (TRC) - ONCONOVA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,689
-35.8%
3,782
+6.6%
0.00%
Q2 2023$4,186
+104550.0%
3,548
-32.4%
0.00%
Q1 2023$4
-99.9%
5,245
+254.6%
0.00%
Q1 2022$3,000
-62.5%
1,479
-52.2%
0.00%
Q4 2021$8,000
-63.6%
3,096
-47.2%
0.00%
-100.0%
Q3 2021$22,0005,859
+13850.0%
0.00%
Q2 2021$0420.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Hillcrest Wealth Advisors - NY, LLC 16,723$11,8970.01%
EDMOND DE ROTHSCHILD HOLDING S.A. 6,666$4,7420.00%
TWO SIGMA INVESTMENTS, LP 124,703$88,7140.00%
OSAIC HOLDINGS, INC. 1,004$7140.00%
BANK OF AMERICA CORP /DE/ 33$230.00%
WELLS FARGO & COMPANY/MN 153$1090.00%
NORTHERN TRUST CORP 30,783$21,8990.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,613$1,1640.00%
GEODE CAPITAL MANAGEMENT, LLC 192,858$139,2110.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders